Oral Rimegepant in Adults With Migraine and Cardiovascular Risk Factors

<p>Dr. Susan Hutchinson discusses her abstract, "Oral Rimegepant 75 mg is Safe and Well Tolerated in Adults With Migraine and Cardiovascular Risk Factors: Results of a Multicenter, Long-Term, Open-Label Safety Study".</p> <p>You can view her abstract and others here<a class= "waffle-rich-text-link" href= "https://index.mirasmart.com/AAN2021/">:</a> <a class= "waffle-rich-text-link" href= "https://index.mirasmart.com/AAN2021/">https://index.mirasmart.com/AAN202</a>1/</p>